期刊文献+

CK19及β-catenin在原发性肝细胞肝癌中的表达及其临床意义 被引量:9

Expression and correlation of CK19 and β-catenin in primary hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨CK19、β-catenin在原发性肝细胞肝癌中的表达及其与临床病理学特征的关系。方法采用免疫组织化学S-P法检测肝脏不同病变组织中(正常肝组织30例,肝炎30例,肝硬化30例,早期肝癌30例,进展期肝癌80例)CK19、β-catenin蛋白的表达情况,分析CK19、β-catenin蛋白表达的差异及其与临床病理学特征的相关性。结果 CK19和β-catenin在早期肝癌和进展期肝癌中的表达均明显高于非肿瘤性肝组织,差异有统计学意义(P<0.05)。CK19在肝细胞肝癌中阳性表达与有无癌栓、淋巴结转移、卫星灶、术后无瘤生存时间有一定相关性(P<0.05);β-catenin在肝细胞肝癌中的异常表达与肿瘤分化程度、肝被膜浸润、卫星灶等因素有一定相关性(P<0.05)。Spearman等级相关性分析显示,CK19和β-catenin在肝细胞肝癌中的表达无明显相关性。CK19和β-catenin异常表达患者较无表达患者预后差,且CK19的表达与患者预后有一定相关性(P<0.05)。结论CK19和β-catenin在肝细胞肝癌中的表达,提示二者在肝癌的发生、发展中起一定作用,且对肝细胞肝癌的生物学行为判断及预后评估有一定参考价值。 Objective To investigate the expression of CK19,β-catenin in primary hepatocellular carcinoma and the association with clinicopathological features.Methods The expression of CK19 and β-catenin in different liver lesions were detected by immunohistochemistry SP method,including 30 cases of normal liver tissues,30 cases of hepatitis,30 cases of cirrhosis,30 cases of early stage hepatocellular carcinoma and 80 cases of advanced hepatocellular carcinoma.Results The expression of CK19 and β-catenin in hepatocellular carcinoma were significantly higher than those in non-tumor liver tissues,and the results were statistically significant(P 0.05).The expression of CK19 was related with cancer embolus,lymph node metastasis,satellite lesions,postoperative survival time(P 0.05),and expression ofβ-catenin was related with tumor differentiation,capsule infiltration,satellite lesions(P 0.05).Spearman rank correlation analysis revealed that expression of CK19 and β-catenin in hepatocellular carcinoma was no significant correlation.CK19 and β-catenin abnormal expression revealed a poor prognosis,and expression of CK19 had a certain relevance with the prognosis of patients.Conclusion The expression of CK19andβ-catenin played the role in the development of hepatocellular carcinoma,which would provide the reference for the biological behavior and prognosis judgment of hepatocellular carcinoma.
出处 《新疆医科大学学报》 CAS 2016年第8期1004-1008,1011,共6页 Journal of Xinjiang Medical University
基金 新疆医学动物模型研究重点实验室开放课题(XJDX1103-2011-03) 新疆维吾尔自治区卫生厅青年科技人才专项科研基金(2013Y01)
关键词 肝细胞肝癌 免疫组化 CK19 Β-CATENIN 临床病理学特征 hepatocellularcarcinoma immunohistochemistry CK19 β-catenin clinicopathological features
  • 相关文献

参考文献2

二级参考文献37

  • 1匡志鹏,谢裕安,杨帆,梁安民,罗小玲,吴继宁.C57BL/6J小鼠肝癌动物模型的建立[J].中国普通外科杂志,2007,16(7):657-660. 被引量:37
  • 2Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future pros- pects. Semin Liver Dis 2010; 30:61-74.
  • 3Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebou- issou S, Jeannot E, H6rault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. Transcrip- tome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45:42-52.
  • 4Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, Shibata T. Geneti- cally distinct and clinically relevant classification of hepato- cellular carcinoma: putative therapeutic targets. Gastroenter- ology 2007; 133:1475-1486.
  • 5Roncalli M, Park YN, Di Tommaso L. Histopathological classification of hepatocellular carcinoma. Dig Liver Dis 2010; 42 Suppl 3:S228-S234.
  • 6Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO clas- sification of tumours of the digestive system. 4th ed. Lyon: IARC, 2010.
  • 7Lu XY, Xi T, Lau WY, Dong H, Zhu Z, Shen F, Wu MC, Cong WM. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behav- ior. Ann Surg Onco12011; 18:2210-2217.
  • 8Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D. Combined he- patocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94:2040-2046.
  • 9Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, Rhee JC, Cho JW, Park CK, Kim HJ. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005; 189:120-125.
  • 10Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza EE. Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Patho12008; 1:43-47.

共引文献13

同被引文献63

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部